Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Catalyst Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Catalyst Pharmaceuticals Inc
Rating: 2.9683055
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

22.52 0.33 (1.49%)

55.63% Gain from 52W Low

720.8K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

High Financial Strength

72.2 / 100

Mid Valuation

43.0 / 100

Technically Neutral

50.0 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

34

1Yr Price target upside is 50%

8 analysts

Catalyst Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Catalyst Pharmaceuticals Inc FAQ

How is Catalyst Pharmaceuticals Inc today?

Catalyst Pharmaceuticals Inc today is trading in the green, and is up by 1.49% at 22.52.

How has Catalyst Pharmaceuticals Inc performed historically?

Catalyst Pharmaceuticals Inc is currently trading up 1.49% on an intraday basis. In the past week the stock rose 2.13%. stock has been down -1.14% in the past quarter and rose 48.84% in the past year. You can view this in the overview section.